Director/PDMR Shareholding
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||||
a) | Name | Declan Giblin | ||||||
2 | Reason for the notification
| |||||||
a) | Position/status | Chief Executive of Latin American Division and Executive Director / PDMR
| ||||||
b) | Initial Notification Amendment | Initial Notification
| ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | Origin Enterprises plc
| ||||||
b) | LEI | 213800AIB4U7N5BLS350
| ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument Identification code | Origin Enterprises plc Ordinary Shares of €0.01 each
IE00B1WV4493 | ||||||
b) | Nature of the transaction | Purchase of Shares | ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information - Aggregated volume - Price |
Total of 10,000 shares purchased Weighted average price: €2.22
| ||||||
e) | Date of the transaction | 1 April 2020 (1,500 shares) and 2 April 2020 (8,500 shares)
| ||||||
f) | Place of the transaction | Dublin, Ireland
| ||||||
g) | Additional Information | Following the transaction(s) disclosed here Declan Giblin beneficially owns 362,735 ordinary shares of €0.01 each in Origin Enterprises plc, representing 0.29% of the company's issued share capital excluding treasury shares. |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.